The delivery of genetic materials into cells to elicit cellular response has been greatly studied by biomaterials scientists globally. Many materials such as lipids, peptides, viruses, synthetically modified cationic polymers and certain inorganic nanomaterials could be used to complex the negatively charged plasmids and deliver the formed package into cells. The recent literature on the delivery of genetic material utilising inorganic nanoparticles is carefully examined in this review. We pick out the most relevant references and concisely summarise the findings with illustrated examples. We further propose alternative approaches and suggest future pathways towards the practical use of multifunctional nanocarriers.
INTRODUCTION

Gene delivery
Recent advances in gene therapy have paved the way towards the effective treatment of human diseases originating from defective genes, such as cancers, Parkinson's disease, cystic fibrosis and muscular degeneration. [1] [2] [3] [4] Effective and specific in vivo delivery of therapeutic genetic materials into a cell, however, remains as a major challenge and is generally considered as the crucial factor in determining the potency of a particular gene therapy. [5] [6] [7] [8] In spite of their high efficiency and common usage in gene delivery, viral vectors inherit fundamental drawbacks (immunological problems, insertional mutagenesis and limitations in the size of the carried therapeutic genes) that need to be addressed before any human clinical trials can be safely conducted. 7 Polymeric, lipid and peptide carriers have been extensively studied in recent years. [9] [10] [11] [12] [13] [14] [15] [16] [17] Functional inorganic nanomaterials recently emerged as robust and versatile nanoscaffolds for effective gene delivery applications. 5, 6 Significantly, without the limitations associated with viral vectors, inorganic nanomaterials further offer an appealing set of properties for practical applications, including scalability in synthesis, facile functionalization, chemical and thermal stability. These properties are important for sterilization, low inherent toxicity (especially for gold, iron oxide and silica nanoparticles), availability in a wide range of size and shape, and the possibility of real-time tracking by various spectroscopic techniques.
Concept
In general, an effective nanocarrier needs to provide robust protection of nucleic acid from degradation by nucleases, efficient cell entry through the cell membrane, and release of the nucleic acid in its functional form within the nucleus (Scheme 1). 18 This was typically achieved by tailoring the size and the surface functionalities (charges, hydrophobicity, and targeting groups) of the nanomaterials employed in gene delivery. Owing to the phosphate backbone, DNA and small interfering RNA (siRNA) are negatively charged moieties. Hence, nanoscaffolds with positively charged surface groups can noncovalently conjugate to DNA or RNA via electrostatic attractions, as have been widely employed in various nanoscaffold delivery systems. Another approach involves covalent tethering of genetic materials onto the nanoscaffolds, where subsequent release of genetic materials is triggered by a specific stimulus either internally or externally (Scheme 1). Plasmid DNA and siRNA are the two main categories of genetic material to be delivered to cells for gene therapy. siRNA is able to cause RNA interference (RNAi) and post-transcriptional gene silencing. This has sparked research interest in utilising RNAi for both biomedical research and therapeutic applications.
Due to high negative charges, 'naked' plasmid DNA and siRNA cannot cross cellular membranes freely. Meanwhile, siRNA is easily digested by enzymes and DNase existing in the environment. Therefore, siRNA must be delivered under protection before reaching its destination and then be activated after delivery. The carriers must meet several requirements to be effective, including the ability to condense genetic materials into compact complexes that can be readily taken up by cells, efficient protection of genetic material from degradation by nucleases, and release of the genetic material in functional form.
Scheme 1. Fundamental steps of gene delivery by nanocarriers (orange spheres).
Delivery and tracking
Specific delivery and efficient release of genetic materials from their carriers are prerequisites for an effective therapy. Specific delivery / targeting could be achieved "actively" or "passively". 19, 20 "Active" targeting involves delivery of genetic materials aided either internally by the molecular-recognition-driven binding between a functional nanocarrier and the receptors on the membrane of a target cell, or externally by a magnetic gradient as in the case of magnetic nanoparticles. On the other hand, "passive" targeting relies on kinetically driven pre-concentration of genetic materials in unhealthy tissues by extravasation through the leaky blood vessels with 600 nm gaps. This type of enhanced permeation and retention effect (EPR) favors loaded nanoscaffolds with a tailored size of around 5-10 nm to "passively" target on the unhealthy tissues. 21 Nevertheless, non-specific uptake and potential degradation by macrophages can be problematic for systems relying only on the "passive" targeting method. Pun et al. recently reported the effects of various physicochemical parameters (size, PEGylation, and ligand type) on regulating non-specific versus targetspecific uptake. 22 Release of genetic payload from the nanocarriers could similarly be triggered by internal (e.g. glutathione (GSH), or pH) or external (e.g. light) stimuli. [23] [24] [25] Notably, biochemical control can be achieved utilising the internal stimuli, whereas spatiotemporal control can be done utilising external stimuli.
There exist other factors that determine the effectiveness of gene therapy, including the coexistence of numerous gene mutations in many diseases and the short lifetime of therapeutic DNA within the dividing cells. On top of that, real-time non-invasive visualization of the delivery event was shown to be an important criterion in assessing the mechanism of a given gene therapy. 8 Hence, there are an increasing number of delivery systems incorporated with various probes for monitoring the delivery process. Nanoscaffold delivery systems are advantageous in this aspect owing to their unique optical and/or magnetic properties allowing non-invasive and spatio-temporal molecular imaging of gene delivery.
NANOPARTICLES FOR GENE DELIVERY
In recent publications, inorganic nanoparticles such as, gold nanoparticles, iron oxide nanoparticles, and quantum dots, have been reported as alternative gene delivery vehicles.
This was suggested on account of their unique intracellular behaviors with powerful cellular imaging capacities. The following sections will discuss various types of inorganic nanoparticles and nanoscaffolds that have been suggested and the current stage of their research thus far.
Gold nanoparticles (AuNPs)
AuNPs have been popularly studied as multifunctional gene carriers due to their ease of synthesis, excellent biocompatibility, well-defined surface chemistry, and facile molecular imaging utilising fluorescence resonance energy transfer (FRET). A typical methodology for the preparation of AuNP-based gene delivery vectors is via surface functionalization of the nanoparticles with positively charged molecules such as amino acids, cationic peptides, and tertiary amine-containing molecules ( Figure 1) . 26, 27 This creates a positively charged scaffold allowing the binding of DNA or siRNA for the formation of complexes which can then be taken up by the cells. Other methods include the exploitation of gold-thiol chemistry to conjugate genetic materials directly onto AuNPs as well as the layer-by-layer assembly of PEI and siRNA to form the gene nanocarriers. However, a major drawback of these methods is that the synthetic process requires multi-step surface functionalization and subsequent conjugation with cationic moieties. This produces a heterogeneous mixture of polyelectrolyte complexes which limits the effectiveness of these gene carriers. Recently, a new method to circumvent this effect was developed to prepare highly efficient and non-toxic AuNP gene carriers with controlled size and surface charge. 28 In that work, controlled synthesis of polyethyleneimine (PEI)-coated AuNPs was achieved utilising catechol-conjugated PEI (PEI-C) for siRNA delivery. 40 The native and the RGD-modified PEGylated dendrimers as well as the Au showing an enhancement of the in vitro transfection levels in human airway epithelial cells compared to static field techniques and Lipofectamine tested. 67 Fouriki et al. investigated the effects of a novel nonviral oscillating magnet array system in enhancing transfection efficiency of primary human mesenchymal stem cells (hMSCs). 68 Plasmids encoding for GFP were coupled to magnetic nanoparticles (MNPs) and introduced to hMSCs in culture.
Magnetic nanoparticles
Magnetic fields generated by magnets positioned below the culture plates direct the MNP/DNA complexes to the cells. The oscillation of the magnetic arrays promoted more efficient endocytosis via mechanical stimulation. This improved transfection efficiency as well as cell viability, additionally; the expression of hMSC-specific cell surface markers was unaffected. This technique was also useful for enhancing the transfection of plasmids to NIH3T3 mouse embryonic fibroblasts, MG-63 osteoblasts and adult cardiomyocytes.
69-71
Carbon nanotubes (CNTs)
CNTs have been widely explored for potential biomedical applications since the first publication of CNT in 1991. [72] [73] [74] [75] [76] properties. The authors also showed high transfection efficiency comparable to that of highmolecular weight BPEI, it was also non-toxic and could be extended to siRNA delivery and potentially photothermal therapy. This was further investigated by the same group in the development of an externally stimuli-triggered spatially and temporally controlled gene delivery system. 85 A photothermally controlled gene delivery carrier, synthesized by linking a low molecular-weight BPEI and reduced GO (rGO) through a hydrophilic PEG spacer. The hybrid system forms a stable nano-sized complex with plasmid DNA (pDNA) and showed better gene transfection efficiency without significant toxicity compared to unmodified controls in PC-3 and NIH/3T3 cells. NIR irradiation led to accelerated endosomal escape of polyplexes augmented by locally induced heating of the hybrid system leading to an enhancement of the gene transfection. Chen et al. also showed that this GO-PEI system shows excellent condensation of DNA at a low N/P ratio. 86 The PEI-GO is also greatly less cytotoxic than PEI 25 kDa. The transfection efficiency of PEI-GO was also higher than that of the PEI 25 kDa at optimal mass ratio. Graphene functionalized with oleatepolyamidoamine (PAMAM) dendrimers hybrids were examined for its gene transfection efficiency. 87 The PAMAM dendrimers were densely tethered onto the graphene surface and showed good dispersity and aqueous stability. The hybrid materials did not show significant toxicity to HeLa and MG-63 cells. The delivery of plasmid DNA encoding for GFP was used as an indicator of gene transfection capability of the hybrids. Interestingly, the ultrasonicated graphene shows some gene transfection ability and the surface modification of graphene with oleic acid/PAMAM further improves the gene transfection efficiency by 13 times. Patterned GO substrates were fabricated for gene transfection using an imprinting approach by mechanical pressure (Figure 3) . 88 This methodology does not require additional chemical reagents and is straightforward and robust. PEI/pDNA complexes were selectively preconcentrated on GO designs, and can be made to release in a sustainable manner. The patterned GO substrates exhibit excellent biocompatibilities and deliver genes encoding for GFP efficiently in a localized manner showing clear boundaries with groups of cells cultured on adjacent areas of the glass. The toxicity of the graphene has been a subject of intense study as well. This is covered in depth in a recent review. 89 Graphene appears not to have much toxicity against selected bacteria and a mild cytotoxic action on Caco-2 cells after 24 h of exposure. 90 The theoretical evaluation of the toxicity of graphene can be investigated with large-scale all-atom molecular dynamics simulations. 91 It appears that the hydrophobic that graphene quantum dots (size ~3-5 nm) exhibit very low cytotoxicity which was attributed to its ultra-small size and high oxygen content. 93 In vivo studies revealed no material accumulation in the main organs of mice as well as fast clearance of graphene quantum dots through the kidney. However, it is critical to note that when mice were injected with graphene quantum dots and GO (size ~10-30 μm, as comparison) multiple times for in vivo toxicity tests, GO appeared toxic causing death in mice due to GO aggregation whereas the quantum dots showed no obvious influence on mice, even under multi-dosing situations. 
Quantum dots (QDs)
Utilising QDs as siRNA carriers is one of the efficient methods to achieve this purpose because QDs is luminous and can be used as fluorescence probes for living cells, in vivo cancer targeting and diagnostics. [94] [95] [96] [97] [98] Similarly, the group continued to report the approach to utilize FRET for gene delivery with UCNs. 111 In this approach, POPO-3 dye intercalating the green fluorescent protein (GFP)-encoded plasmid DNA was carried by amino-functionalized silica-coated β-NaYF4:Yb, Er UCNs ( Figure 6 ). FRET between POPO-3 and UCNs was checked with confocal microscopy to track DNA attachment or release. They were able to achieve successful in vitro and in vivo delivery of DNA, which were confirmed by expression of its encoded GFP in Hela cells 24 h post-transfection and induction of the antibody against the expressed encoded GFP in immunocompetent mice, respectively. Reproduced from 112 .
In a later work, Liu and Xing et. al reported a NIR light-induced siRNA release system with silica coated UCNs (Si-UCNs). 113 (PEI) via covalent conjugation and layer-by-layer assembly, respectively. They found two layer of PEI modification of UCNs showed superior gene transfection efficiency compared to one layer PEI modification in both serum-free media, but slightly less effective than free PEI polymers. In serum-containing media, UCN-PEG@2×PEI showed remarkably enhanced transfection efficiency. Gene delivery could be tracked by both upconversion luminescence and magnetic resonance imaging contrasting ability of UCNs. The above cases showed the possibility of delivering genetic materials with UCNs and to achieve controlled release. To summarize, there are mainly two methods for the UCNs to host the genes as a vector: 1) loading genes in mesoporous silica coated on the UCN surface, 2)
Genes are absorbed on positively charged polymer/antibody coated on UCN via electrostatic force. This technique brings the light controlled gene delivery/knockdown to a deeper level in the tissue using safe NIR light, which adds advantages to gene therapy.
Silica nanoparticles
Mesoporous silica nanoparticle (MSN) is a promising material for biomedical applications, such as delivering drugs or biological molecules (siRNA or DNA) to the target cells or tissues. This is because of focal points, for example, accessibility in permeable structures for encapsulation of medications and genes, extensive surface region to stack biomacromolecules, biocompatibility, material stability, and simple synthesis at cost efficient rates. With positivecharge functionalization on their surface, MSNs are suitable as vectors for siRNA delivery.
MSNs with small pore size (~3 nm) have been utilized for plasmid delivery. Xia et al.
reported the use of MSNs modified with PEI to adsorb negatively charged plasmid DNA onto the surface for loading and cellular delivery. 117 Others used cationic materials such as dendrimers 118 and cationic lipids 119 for surface modification. Modification of the surface with cationic components was necessary for DNA adsorption. [120] [121] [122] However, the mixing of the genetic material with the MSNs does not fully utilize the mesopores and prevents further modifications on the particle surface. Furthermore, DNAs that are conjugated or adsorbed onto a nanoparticle surface can be easily degraded by nucleases. Therefore, it would be ideal if DNAs are packaged into a protective space for protection against degradation until they are 
Conclusion and Outlook
At present, the examination of inorganic nanoparticles for good gene delivery is at a developmental stage and one could expect that numerous specialists would be laying cases to their developments. Prior to making a choice on the kind of nanoparticle for good gene delivery applications, a few inquiries must be tended to: What is the quality transfection proficiency? What happens to the nanoparticles after utilization? Are these nanoparticles good for utilization in the body? From these contemplations, research into inorganic nanoparticles for good gene delivery can be visualized to develop in the accompanying areas:
i) advancement of novel nanomaterials for good gene delivery; ii) key structure-property relationship examination on cytotoxicity and transfection productivity; iii) lifetime studies;
and iv) in vivo practical studies. The examination of vectors for good gene delivery is a wide field of study. It is impossible that any one material will satisfy the necessities of all the diverse applications. Consequently, new materials or mixes of materials must be produced for 
